OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q2 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $25,000 | +4.2% | 3,605 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $24,000 | +4.3% | 3,605 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $23,000 | +43.8% | 3,605 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $16,000 | -27.3% | 3,605 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $22,000 | -33.3% | 3,605 | 0.0% | 0.01% | -40.0% |
| Q2 2017 | $33,000 | 0.0% | 3,605 | 0.0% | 0.01% | -9.1% |
| Q1 2017 | $33,000 | +10.0% | 3,605 | 0.0% | 0.01% | -8.3% |
| Q4 2016 | $30,000 | +20.0% | 3,605 | 0.0% | 0.01% | +9.1% |
| Q3 2016 | $25,000 | +38.9% | 3,605 | 0.0% | 0.01% | +37.5% |
| Q2 2016 | $18,000 | +1700.0% | 3,605 | +3505.0% | 0.01% | – |
| Q1 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |